The Use of Surface Plasmon Resonance for the Detection and Characterization of Antibodies

Detection and Quantification of Antibodies to Biopharmaceuticals: Practical and Applied Considerations

Volumn , Issue , 2011, Pages 193-209

  Swanson, Steven J ^a   Mytych, Daniel ^a  

^a AMGEN INC   (United States)

Author keywords

"surface plasmon resonance immunoassay" (SPRIA) SPR based systems for detection; Nature of antibody response, immune response maturing, producing IgG antibodies; Surface plasmon resonance detection, and antibody characterization

Indexed keywords

EID: 84868572754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118075685.ch11     Document Type: Chapter

References (19)

1. Swanson, S.J., Jacobs, S.J., et al. ( 1999 ). Applications for the new electrochemiluminescent (ECL) and biosensor technologies . Dev Biol Stand, 97, 135-147 .
2. Moxness, M., Tatarewicz, S., Weeraratne, D., Murakami, N., Wullner, D., Mytych, D., Jawa, V., Koren, E., Swanson, S.J. ( 2005 ). Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies . Clin Chem, 51 ( 10 ), 1983-1985 .
3. Fagerstam, L.G., Frostell, A., et al. ( 1990 ). Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping . J Mol Recognit, 3 ( 5-6 ), 208-214 .
4. Malmborg, A.C., Michaelsson, A., et al. ( 1992 ). Real time analysis of antibody-antigen reaction kinetics . Scand J Immunol, 35 ( 6 ), 643-650 .
5. Malmqvist, M. ( 1993 ). Biospecific interaction analysis using biosensor technology . Nature, 361 ( 6408 ), 186-187 .
6. Baird, C.L., Myszka, D.G. ( 2001 ). Current and emerging commercial optical biosensors . J Mol Recognit, 14 ( 5 ), 261-268 .
7. Mytych, D., La, S., Barger, T., Ferbas, J., Swanson, S. ( 2009 ). The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum . J Pharm Biomed Anal, 49, 415-426 .
8. Wong, R.L., Mytych, D., et al. ( 1997 ). Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies . J Immunol Methods, 209 ( 1 ), 1-15 .
9. Takacs, M.A., Jacobs, S.J., et al. ( 1999 ). Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance . J Interferon Cytokine Res, 19 ( 7 ), 781-789 .
10. Alaedini, A., Latov, N. ( 2001 ). A surface plasmon resonance biosensor assay for measurement of anti-GM(1) antibodies in neuropathy . Neurology, 56 ( 7 ), 855-860 .
11. Abad, L.W., Neumann, M., et al. ( 2002 ). Development of a biosensor-based method for detection and isotyping of antibody responses to adenoviral-based gene therapy vectors . Anal Biochem, 310 ( 1 ), 107-113 .
12. Swanson, S.J., Mytych, D., et al. ( 2002 ). Use of biosensors to monitor the immune response . Dev Biol (Basel), 109, 71-78 .
13. Wadhwa, M., Bird, C., et al. ( 2003 ). Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals . J Immunol Methods, 278, ( 1-2 ), 1-17 .
14. Mire-Sluis, A.R., Barrett, Y.C., et al. ( 2004 ). Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products . J Immunol Methods, 289 ( 1-2 ), 1-16 .
15. Swanson, S.J., Ferbas, J., et al. ( 2004 ). Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin . Nephron Clin Pract, 96 ( 3 ), c88-c95 .
16. Koren, E., Zuckerman, L., Mire-Sluis, A.R. ( 2002 ). Immune responses to therapeutic proteins in humans: clinical significance, assessment and prediction . Current Pharmaceutical Biotechnol, 3 ( 4 ), 349-360 .
17. Tatarewicz, S., Wei, X., Gupta, S., Masterman, D., Swanson . S.J., Moxness, M. ( 2007 ). Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson ' s disease receiving r-metHuGDNF via continuous intraputaminal infusion . J Clin Immunology, 27, 620-627 .
18. Lofgren, J., Dhandapani, S., Pennucci, J., Abbott, C., Mytych, D., Kaliyaperumal, A., Swanson, S.J., Mullenix, M.C. ( 2007 ). Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab . J Immunol, 178 (11), 7467-7472 .
19. Ponce, R., Abad, L., Amaravadi, L., Gelzleichter, T., Gore, E., Green, J., Gupta, S., Herzyk, D., Hurst, C., Ivens, I., Kawabata, T., Maier, J., Mounho, B., Rup, B., Shankar, G., Smith, H., Thomas, P., Wierda, D. ( 2009 ). Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies . Regul Toxicol Pharmacol, 54, 164-182 .